Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022

Stock Information for Cannara Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cannara Biotech Inc.

The Lovesac Company Appoints Heidi Cooley as Chief Brand and Marketing Officer
The Lovesac Company Reports Fourth Quarter And Fiscal 2025 Financial Results
The Lovesac Company Named As 2025 Bronze Edison Award Winner
The Lovesac Company Announces Fourth Quarter and Fiscal 2025 Conference Call Date
Lovesac Revives Recliner Culture with Kathy Hilton, Jay Shetty and Funny Marco in New Campaign
Lovesac and Habitat for Humanity Partner to Bring Total Comfort to Communities Nationwide
The Lovesac Company Announces Participation in the 2025 ICR Conference
The Lovesac Company Publishes 2024 ESG Report

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.